Author:
Tang Xiaoli,Liu Hong,Rao Rongjia,Huang Yafei,Dong Mengqi,Xu Miaomiao,Feng Shanshan,Shi Xun,Wang Li,Wang Zengwu,Zhou Bingying
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Environmental Science,General Biochemistry, Genetics and Molecular Biology
Reference115 articles.
1. Abi-Gerges, N., Indersmitten, T., Truong, K., Nguyen, W., Ratchada, P., Nguyen, N., Page, G., Miller, P.E., and Ghetti, A. (2020a). Multiparametric mechanistic profiling of inotropic drugs in adult human primary cardiomyocytes. Sci Rep 10, 7692.
2. Abi-Gerges, N., McMahon, C., Vargas, H., Sager, P., Chui, R., Stevens, D., Davila, J., Schaub, J.R., Wu, J.C., del Rio, C., et al. (2019). The West coast regional safety pharmacology society meeting update: Filling translational gaps in safety assessment. J Pharmacol Toxicol Methods 98, 106582.
3. Abi-Gerges, N., Miller, P.E., and Ghetti, A. (2020b). Human heart cardiomyocytes in drug discovery and research: new opportunities in translational sciences. Curr Pharm Biotechnol 21, 787–806.
4. Agency, E.M. (2020). Summary on Compassionate Use. Remdesivir Gilead. Available from URL: https://www.ema.europa.eu/en/documents/other/summary-compassionate-use-remdesivir-gilead_en.pdf.
5. Appu, G.V., Joshi, D.A., Bavage, S.B., and Bavage, S.B. (2021). Adverse drug event reporting of remdesivir. Int J Innov Res Technol 8, 159–161.